Trials / Unknown
UnknownNCT02844959
Inflammatory Response as a Prognostic Factor of Recurrence of Atrial Fibrillation After Ablation
Assessment of Course of Inflammatory Biomarkers Concentrations After Pulmonary Veins Isolation as a Prognostic Factor of Atrial Fibrillation Treatment Effectiveness (ACtIVE-AF Study)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (estimated)
- Sponsor
- Medical University of Warsaw · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to evaluate inflammatory response as a prognostic factor of atrial fibrillation recurrency after ablation. Inflammatory response will be assessed by double measurement of C-reactive protein, fibroblast growth factor 2 (FGF2), matrix metallopeptidase 8 (MMP8) and body temperature. Dynamics of change of troponin I will be measured additionally. After ablation each patient will be monitored with ECG telemonitoring system for 7 days.
Conditions
Timeline
- Start date
- 2016-07-01
- Primary completion
- 2017-07-01
- Completion
- 2018-07-01
- First posted
- 2016-07-26
- Last updated
- 2016-07-26
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT02844959. Inclusion in this directory is not an endorsement.